TMDX — TransMedics Group Inc. price, chart and key statistics

Price data

Price

$74.75

YTD price return

-38.55%

YTD total return

-38.55%

Next earnings

Nov 4, 2026

Market cap

2.6B2019-06 611.5M2026-10 2.6B+323.9% over the window

Enterprise value

2.5B

Shares outstanding

34.7M2018-12 1.4M2026-06 34.7M+2381.2% over the window

52W low

$60.11

52W high

$156.00

From 52W high

-52.08%

From 52W low

+24.37%

52W range

15%

Volume

Rel volume

1.44×

30D volume

814.9K

30D $ vol

66.4M

Fundamentals

Sales (ttm)

668.5M2018-12 14.7M2026-06 668.5M+4460.7% over the window

Sales/share

$19.282018-12 $10.492026-06 $19.28+83.8% over the window

EPS (ttm)

$3.832020-03 -$1.672026-06 $3.83-328.7% over the window

FCF (ttm)

79M2018-12 -26.4M2026-06 79M-399.4% over the window

FCF/share

$2.282018-12 -$18.892026-06 $2.28-112.1% over the window

Book value/share

$14.942018-06 -$128.562026-06 $14.94-111.6% over the window

Net margin

22.69%2018-12 -162.1%2026-06 22.7%-114.0% over the window

ROE

29.28%2019-06 -40.5%2026-06 29.3%-172.3% over the window

ROA

10.36%2018-12 -56.4%2026-06 10.4%-118.4% over the window

Current ratio

6.622018-12 2.772026-06 6.62+139.0% over the window

Growth (CAGR, ttm) · 10Y

Sales

+25.84%2025-06-30 → 2026-06-30531.3M → 668.5M (+25.8% total)+64.15%2023-06-30 → 2026-06-30151.1M → 668.5M (+342.5% total)+83.10%2021-06-30 → 2026-06-3032.5M → 668.5M (+1957.2% total)n/a

Net income

+111.80%2025-06-30 → 2026-06-3071.7M → 151.7M (+111.7% total)n/an/an/a

FCF

+355.99%2025-06-30 → 2026-06-3017.4M → 79M (+355.5% total)n/an/an/a

Shares

+1.72%2025-06-30 → 2026-06-3034.1M → 34.7M (+1.7% total)+2.05%2023-06-30 → 2026-06-3032.6M → 34.7M (+6.3% total)+4.61%2021-06-30 → 2026-06-3027.7M → 34.7M (+25.3% total)n/a

Per-share growth (CAGR, ttm) · 10Y

EPS

+102.15%2025-06-30 → 2026-06-30$1.89 → $3.83 (+102.1% total)n/an/an/a

Sales/share

+23.72%2025-06-30 → 2026-06-30$15.58 → $19.28 (+23.7% total)+60.86%2023-06-30 → 2026-06-30$4.63 → $19.28 (+316.4% total)+75.03%2021-06-30 → 2026-06-30$1.17 → $19.28 (+1542.0% total)n/a

FCF/share

+348.29%2025-06-30 → 2026-06-30$0.51 → $2.28 (+347.8% total)n/an/an/a

Book value/share

+60.16%2025-06-30 → 2026-06-30$9.33 → $14.94 (+60.1% total)+49.72%2023-06-30 → 2026-06-30$4.45 → $14.94 (+235.7% total)+35.97%2021-06-30 → 2026-06-30$3.22 → $14.94 (+364.7% total)n/a

Price

-37.68%2025-10-20 → 2026-10-20$119.90 → $74.75 (-37.7% total)Price appreciation from split-adjusted daily closes, excluding dividends; endpoints are exact trading-day anniversaries of the latest close.+21.79%2023-10-20 → 2026-10-20$41.37 → $74.75 (+80.7% total)Price appreciation from split-adjusted daily closes, excluding dividends; endpoints are exact trading-day anniversaries of the latest close.+22.68%2021-10-20 → 2026-10-20$26.90 → $74.75 (+177.9% total)Price appreciation from split-adjusted daily closes, excluding dividends; endpoints are exact trading-day anniversaries of the latest close.n/a

Total return

-37.68%2025-10-20 → 2026-10-20$119.90 → $74.75 (-37.7% total)Total return with dividends reinvested (adjusted daily closes); endpoints are exact trading-day anniversaries of the latest close. The gap against the Price row is the dividend contribution.+21.79%2023-10-20 → 2026-10-20$41.37 → $74.75 (+80.7% total)Total return with dividends reinvested (adjusted daily closes); endpoints are exact trading-day anniversaries of the latest close. The gap against the Price row is the dividend contribution.+22.68%2021-10-20 → 2026-10-20$26.90 → $74.75 (+177.9% total)Total return with dividends reinvested (adjusted daily closes); endpoints are exact trading-day anniversaries of the latest close. The gap against the Price row is the dividend contribution.n/a

Fundamentals end at the last reported quarter; price and total return end at the latest close.

Valuation

P/E (ttm)Price ÷ TTM diluted EPS. Net income carries everything below the operating line, including one-off gains. Negative when the trailing year lost money.

19.5×2019-06 -23.752026-10 17.09-171.9% over the window

Fwd P/E

31.4×

P/S (ttm)Market cap ÷ TTM revenue.

3.9×2019-06 35.572026-10 3.88-89.1% over the window

P/B (mrq)Market cap ÷ stockholders' equity at the most recent quarter end.

5.0×2019-06 -3.072026-10 5.00-262.9% over the window

P/FCF (ttm)Market cap ÷ TTM free cash flow (operating cash flow − capex).

32.8×2019-06 -22.402026-10 32.79-246.4% over the window

EV/EBITDA (fy)

21.0×

EV/Sales (ttm)

3.7×

FCF yield (ttm)TTM free cash flow ÷ market cap — the inverse of P/FCF.

3.05%2019-03 -4.5%2026-06 3.4%-176.9% over the window

Buyback yield (realized, 1y)1 − shares_at(2026-06-30) ÷ shares_at(2025-06-30) = 1 − 34.7M ÷ 34.1M. Point-in-time share counts from the company's own SEC filings (the same count at both ends), published only when the cash flow statement shows repurchases inside that window. A falling price can't inflate it; negative means net dilution.

-1.72%

Shareholder yield (realized, 1y)Buyback leg + dividend leg: shares retired over the year (-1.72%) + dividends paid over that year ($0) ÷ market_cap_at(2025-06-30) ($4.6B). Both legs are measured against the start of the window, so a payout can't shrink its own denominator.

-1.72%

Buyback yield (cash, ttm)Buybacks net of issuance over the trailing twelve months ($0) ÷ today's market cap ($2.6B). Dollars SPENT over what the company is worth NOW — a stock that fell after buying reads high.

0.00%2019-03 0.0%2026-06 0.0%

Shareholder yield (cash, ttm)(TTM buybacks net of issuance $0 + TTM dividends $0) ÷ today's market cap ($2.6B). Same caveat as the cash buyback yield.

0.00%2019-03 0.0%2026-06 0.0%

Vs own 10Y history

P/S

2nd

P/B

10th